Fig. 2
From: Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy
KM distant recurrence and BCSM curves for years 0–5 and >5–10 by RS group. The box under each graph presents the number of patients at risk at each time point. Two-degree of freedom log-rank P-values were calculated from all the data. BCSM breast cancer- specific mortality
